Cathy Harrison/LinkedIn
Jun 24, 2025, 08:09
Cathy Harrison Shares Study on Deprescribing Antithrombotic Therapy in Advanced Cancer Care
Cathy Harrison, WFH nurses committee Chair, shared a post on X:
“Incredibly interesting, mixed methods study on antithrombotic therapy (ATT) during advanced cancer care. Experienced clinicians we’re more likely to deprescribe ATT and patient choice was a key decision maker in that action.”
Don’t miss updates from ISTH 2025 with Hemostasis Today.
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription